These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7544816)

  • 1. Implications of the most bothersome prostatism symptom for clinical care and outcomes research.
    DuBeau CE; Yalla SV; Resnick NM
    J Am Geriatr Soc; 1995 Sep; 43(9):985-92. PubMed ID: 7544816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of symptoms of prostatism on level of bother and quality of life of men in the French community.
    Sagnier PP; MacFarlane G; Teillac P; Botto H; Richard F; Boyle P
    J Urol; 1995 Mar; 153(3 Pt 1):669-73. PubMed ID: 7532230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tamsulosin hydrochloride on lower urinary tract symptoms and quality of life in patients with benign prostatic hyperplasia. Evaluation using bother score.
    Yoshida M; Sugiyama Y; Masunaga K; Maeda Y; Satoji Y; Nagata T; Inadome A
    Drugs Today (Barc); 2007 Jun; 43 Suppl B():1-7. PubMed ID: 17612712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Prostate-related symptoms' in Canadian men 50 years of age or older: prevalence and relationships among symptoms.
    Norman RW; Nickel JC; Fish D; Pickett SN
    Br J Urol; 1994 Nov; 74(5):542-50. PubMed ID: 7530115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of American Urological Association symptom index with obstructive and nonobstructive prostatism.
    Yalla SV; Sullivan MP; Lecamwasam HS; DuBeau CE; Vickers MA; Cravalho EG
    J Urol; 1995 Mar; 153(3 Pt 1):674-9; discussion 679-80. PubMed ID: 7532231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Rosen RC; Fitzpatrick JM;
    BJU Int; 2009 Oct; 104(7):974-83. PubMed ID: 19426189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the International Prostatic Symptom Score and a pressure-flow study in the evaluation of symptomatic benign prostatic hyperplasia.
    Netto Júnior NR; D'Ancona CA; de Lima ML
    J Urol; 1996 Jan; 155(1):200-2. PubMed ID: 7490834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Content validity of the Benign Prostatic Hyperplasia Impact Index (BII); a measure of how urinary trouble and problems associated with BPH may impact the patient.
    Kingery L; Martin ML; Naegeli AN; Khan S; Viktrup L
    Int J Clin Pract; 2012 Sep; 66(9):883-90. PubMed ID: 22897465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting.
    O'Leary MP; Wei JT; Roehrborn CG; Miner M;
    BJU Int; 2008 Jun; 101(12):1531-5. PubMed ID: 18445080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary symptoms in the community: how bothersome are they?
    Jolleys JV; Donovan JL; Nanchahal K; Peters TJ; Abrams P
    Br J Urol; 1994 Nov; 74(5):551-5. PubMed ID: 7530116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WITHDRAWN: Tamsulosin for benign prostatic hyperplasia.
    Wilt TJ; Macdonald R; Rutks I
    Cochrane Database Syst Rev; 2011 Sep; 2011(9):CD002081. PubMed ID: 21901681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamsulosin for benign prostatic hyperplasia.
    Wilt TJ; Mac Donald R; Rutks I
    Cochrane Database Syst Rev; 2003; (1):CD002081. PubMed ID: 12535426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being.
    Eckhardt MD; van Venrooij GE; van Melick HH; Boon TA
    J Urol; 2001 Aug; 166(2):563-8. PubMed ID: 11458069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
    Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
    BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older.
    Safarinejad MR
    Int Urol Nephrol; 2008; 40(4):921-31. PubMed ID: 18246438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the epidemiology and natural history of benign prostatic hyperplasia.
    Boyle P
    Prog Clin Biol Res; 1994; 386():3-18. PubMed ID: 7528398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
    Lepor H; Williford WO; Barry MJ; Haakenson C; Jones K
    J Urol; 1998 Oct; 160(4):1358-67. PubMed ID: 9751354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of quality of life with patient reported symptoms and objective findings in men with benign prostatic hyperplasia. The Department of Veterans Affairs Cooperative Study of transurethral resection for benign prostatic hyperplasia.
    J Urol; 1993 Nov; 150(5 Pt 2):1696-700. PubMed ID: 7692104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.